FDA authorizes marketing of 1st blood test to aid in eval of concussion in adults. Most patients eval ' d for concussion w/ a CT scan don ' t have detectable brain tissue damage. This quick testing option helps reduce the need for CT scans, radiation exposure https://go.usa.gov/xn6vh pic.twitter.com/QQzznfsvmI

FDA authorizes marketing of 1st blood test to aid in eval of concussion in adults. Most patients eval'd for concussion w/ a CT scan don't have detectable brain tissue damage. This quick testing option helps reduce the need for CT scans, radiation exposure https://go.usa.gov/xn6vh pic.twitter.com/QQzznfsvmI

https://twitter.com/US_FDA/status/963842922364981249

Source: Food and Drug Adminstration (FDA): CDRHNew - February 14, 2018 Category: Medical Devices Authors: ( at US_FDA) Source Type: news